BioNTech SE (BNTX) Gains from Investment Securities (2018 - 2025)

BioNTech SE has disclosed Gains from Investment Securities across 8 years of filings, most recently posting -$931234.8 for Q4 2025.

• Gains from Investment Securities for Q4 2025 came in at -$931234.8, down 771.46% year-over-year; the trailing twelve-month figure through Dec 2025 was -$15.6 million (up 94.45% YoY), and the FY2025 annual result was -$2.8 million, down 781.07% from the prior year.
• Gains from Investment Securities came in at -$931234.8 for Q4 2025 at BioNTech SE, up from -$1.5 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $3.6 million in Q3 2023 to a low of -$1.4 billion in Q1 2022.
• The 5-year median for Gains from Investment Securities is -$1.2 million (2021), against an average of -$302.1 million.
• Across the five-year window, Gains from Investment Securities soared 4129.79% in 2021 and sank 1200275504607.64% in 2022, its largest moves.
• BioNTech SE's Gains from Investment Securities stood at $4.8 in 2021, then sank by 29460688124.35% to -$1.4 billion in 2022, then soared by 95.05% to -$70.0 million in 2023, then jumped by 99.85% to -$106859.5 in 2024, then plunged by 771.46% to -$931234.8 in 2025.
• The last three Gains from Investment Securities figures came in at -$931234.8 (Q4 2025), -$1.5 million (Q3 2025), and -$339587.9 (Q2 2025), per Business Quant data.